Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Oruka Therapeutics Inc shares valued at $1,015,803 were purchased by Venrock Healthcare Capital Par on Feb 14 ’25. At $11.44 per share, Venrock Healthcare Capital Par acquired 88,794 shares. The insider’s holdings grew to 4,148,428 shares worth approximately $29.74 million following the completion of this transaction.
Also, Venrock Healthcare Capital Par purchased 14,950 shares, netting a total of over 173,868 in proceeds. Following the buying of shares at $11.63 each, the insider now holds 4,059,634 shares.
Before that, Venrock Healthcare Capital Par had added 8,971 shares to its account. In a trade valued at $106,396, the 10% Owner bought Oruka Therapeutics Inc shares for $11.86 each. Upon closing the transaction, the insider’s holdings increased to 8,971 shares, worth approximately $29.0 million.
As published in their initiating research note from Wolfe Research on February 04, 2025, Oruka Therapeutics Inc [ORKA] has been an Outperform and the price target has been revised to $20. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in mid October. As of October 07, 2024, H.C. Wainwright has initiated its “Buy” rating for ORKA. Earlier on September 17, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for ORKA stock.
Analyzing ORKA Stock Performance
During the last five days, there has been a drop of approximately -23.89%. Over the course of the year, Oruka Therapeutics Inc shares have dropped approximately -63.02%. Shares of the company reached a 52-week high of $21.32 on 01/06/25 and a 52-week low of $5.49 on 04/09/25. A 50-day SMA is recorded $11.01, while a 200-day SMA reached $24.05.
Support And Resistance Levels for Oruka Therapeutics Inc (ORKA)
According to the 24-hour chart, there is a support level at 5.96, which, if violated, would cause prices to drop to 4.74. In the upper region, resistance lies at 7.91. The next price resistance is at 8.65. RSI (Relative Strength Index) is 28.97 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.80, which suggests the price will decrease in the coming days. Percent R is at 76.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
